Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Mar 21, 2023; 29(11): 1735-1744
Published online Mar 21, 2023. doi: 10.3748/wjg.v29.i11.1735
Figure 1
Figure 1 Description of the study flowchart.
Figure 2
Figure 2 Hematoxylin-eosin staining. A: The hematoxylin-eosin (HE) staining of N1c; B: The HE staining of non-N1c.
Figure 3
Figure 3 Overall survival. A: The overall survival of the patient with/without lymphovascular invasion (LVI); B: The overall survival of the non-N1c patient with/without LVI; C: The overall survival of the N1c patient with/without LVI.
Figure 4
Figure 4 Disease-free survival. A: The disease-free survival of the patients with/without lymphovascular invasion (LVI); B: The disease-free survival of the non-N1c patient with/without LVI; C: The disease-free survival of the N1c patient with/without LVI.